HealthMore in Health→
Novo Nordisk Says 1 Million Obesity Patients Are Already Taking Its Wegovy Pill
Key Takeaways
- Novo Nordisk said one million obesity patients are already taking its Wegovy pill.
- The company reported 2.3 billion Danish kroner in pill sales, according to the supplied source text.
- Management framed the quarter around pills, pricing, payments, and pressure as competition intensifies.
DE
DT Editorial Team··via endpoints.news